Compounds > edotreotide
Page last updated: 2024-09-04

edotreotide and Pituitary Neoplasms

edotreotide has been researched along with Pituitary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Casar-Borota, O; Filipsson Nyström, H; Gjertsson, P; Heurling, K; Himmelman, J; Itsenko, O; Ragnarsson, O; Schöll, M; Tjörnstrand, A1
Christ, ER; Komor, J; Reubi, JC1

Other Studies

2 other study(ies) available for edotreotide and Pituitary Neoplasms

ArticleYear
Lower
    Clinical endocrinology, 2020, Volume: 92, Issue:3

    Topics: Adult; Aged; Case-Control Studies; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pituitary Gland; Pituitary Neoplasms; Positron-Emission Tomography; Proof of Concept Study; Prospective Studies

2020
Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma.
    Pituitary, 2014, Volume: 17, Issue:3

    Topics: Adult; Combined Modality Therapy; Humans; Male; Octreotide; Ophthalmoplegia; Pituitary Neoplasms; Radiopharmaceuticals; Receptors, Peptide; Receptors, Somatostatin; Somatostatin

2014